Related Experiment Videos
Macrophage mediated tumor cell cytotoxicity
Abstract:
The following evidence from our research has implicated the macrophage as an important effector cell in pyran and/or C. parvum induced host resistance to solid tumors: (1) Increased infiltration of tumors with histiocytes following systemic treatment with pyran;17 (2) activated peritoneal macrophages with tumoricidal activity have been recovered from the peritoneal cavity of normal or tumor bearing mice treated with pyran or C. parvum;17 (3) activated peritoneal macrophages mixed with tumor cells in vitro and transplanted into syngeneic recipients inhibited tumor growth; (4) trypan blue, an inhibitor of macrophage function, prevent C. parvum induced regression of methylcholanthrene tumors; and (5) direct intralesional injection of activated macrophages into the MCA 2182 tumor inhibited tumor growth and increased the MST.
Insights
Macrophages play a key role in host resistance to solid tumors when treated with pyran or Corynebacterium parvum (C. parvum). These immune cells demonstrate tumoricidal activity and inhibit tumor growth, offering therapeutic potential.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Solid tumors pose a significant challenge in cancer therapy.
- Understanding host resistance mechanisms is crucial for developing effective treatments.
- Macrophages are immune cells with diverse roles, including potential anti-tumor functions.
Purpose of the Study:
- To investigate the role of macrophages in pyran and/or C. parvum-induced host resistance to solid tumors.
- To evaluate the anti-tumor potential of activated macrophages.
Main Methods:
- Systemic treatment of tumor-bearing mice with pyran or C. parvum.
- Analysis of macrophage infiltration into tumors.
- Isolation and functional assessment of peritoneal macrophages.
- In vitro and in vivo experiments using activated macrophages and tumor cells.
- Inhibition of macrophage function using trypan blue.
Main Results:
- Pyran treatment led to increased macrophage infiltration in tumors.
- Activated macrophages from treated mice exhibited tumoricidal activity.
- Adoptive transfer of activated macrophages inhibited tumor growth in syngeneic recipients.
- Inhibition of macrophage function with trypan blue abrogated C. parvum-induced tumor regression.
- Direct intralesional injection of activated macrophages suppressed tumor growth and increased median survival time (MST).
Conclusions:
- Macrophages are critical effector cells in pyran and/or C. parvum-mediated anti-tumor responses.
- Activated macrophages possess significant tumoricidal and tumor-inhibitory capabilities.
- Targeting macrophages represents a promising strategy for solid tumor immunotherapy.